Positron Emission Tomography in Lymphoma: Comparison with Computed Tomography and Gallium-67 Single Photon Emission Computed Tomography

This publication has 35 references indexed in Scilit:

• The role of gallium-67 in the clinical evaluation of cancer
  Published by Elsevier ,2006
• Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging
  Blood, 1999
• Whole-body 18F-FDG PET for the evaluation of patients with Hodgkinʼs disease and non-Hodgkinʼs lymphoma
  Nuclear Medicine Communications, 1999
• Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma
  Nuclear Medicine Communications, 1998
• Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
  Radiology, 1997
• Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study
  Magnetic Resonance Materials in Physics, Biology and Medicine, 1996
• Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
  Radiology, 1994
• A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease
  European Journal Of Cancer, 1992
• Computed tomography of abdominal paraaortic lymph node disease: preliminary observations with a 6 second scanner
  American Journal of Roentgenology, 1977